Mr Market beams as investors run from pillar-to-post trying to find the best bet for an investment. And even as some stocks go bonkers at the exchange, Pharma investors repeatedly convince themselves to be patient.
As we all wait for Eli Lilly (NYSE: LLY) to come out with its Q4 results, a question looms above us: Will Eli Lilly bear down on one’s portfolio?
That is indeed a question more »
Why would you toss your hard-earned money down the confusing labyrinth of Mr. Market? The answer is simple, like any other investor you want ROI! But fishing out a stock which reflects strength and strategic management decisions is what lays the foundation for a desirable buyer-stock interlude.
PPG Industries ) has long attracted my interest. A fine fourth-quarter performance was expected from this competitive chemical maker, but what charms me is more »